Principal Financial Group Inc Intercept Pharmaceuticals, Inc. Transaction History

Principal Financial Group Inc

$160 Billion
Q2 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 02, 2023	BUY	$9.99 - $18.71 $121,738 - $228,000	12,186 Added 44.08%	39,832 $738,000
Q2 2023 Aug 07, 2023	BUY	$9.17 - $19.29 $72,378 - $152,255	7,893 Added 39.96%	27,646 $305,000
Q1 2023 May 09, 2023	SELL	$12.53 - $21.71 $40,033 - $69,363	-3,195 Reduced 13.92%	19,753 $265,000
Q4 2022 Feb 09, 2023	BUY	$11.61 - $16.11 $36,652 - $50,859	3,157 Added 15.95%	22,948 $283,000
Q3 2022 Nov 09, 2022	SELL	$12.21 - $19.7 $275,103 - $443,860	-22,531 Reduced 53.24%	19,791 $276,000
Q2 2022 Aug 10, 2022	SELL	$11.23 - $19.59 $243,376 - $424,554	-21,672 Reduced 33.87%	42,322 $584,000
Q1 2022 May 09, 2022	SELL	$13.37 - $17.79 $412,023 - $548,234	-30,817 Reduced 32.5%	63,994 $1.04 Million
Q4 2021 Feb 09, 2022	BUY	$14.28 - $19.53 $38,827 - $53,102	2,719 Added 2.95%	94,811 $1.54 Million
Q3 2021 Nov 09, 2021	SELL	$12.99 - $20.47 $22,134 - $34,880	-1,704 Reduced 1.82%	92,092 $1.37 Million
Q2 2021 Aug 10, 2021	SELL	$15.46 - $24.5 $40,737 - $64,557	-2,635 Reduced 2.73%	93,796 $1.87 Million
Q1 2021 May 10, 2021	BUY	$19.33 - $37.75 $141,418 - $276,179	7,316 Added 8.21%	96,431 $2.23 Million
Q4 2020 Feb 08, 2021	BUY	$24.48 - $42.47 $694,717 - $1.21 Million	28,379 Added 46.73%	89,115 $2.2 Million
Q3 2020 Nov 06, 2020	BUY	$39.09 - $53.44 $810,570 - $1.11 Million	20,736 Added 51.84%	60,736 $2.52 Million
Q2 2020 Aug 05, 2020	BUY	$46.7 - $92.04 $1.48 Million - $2.92 Million	31,725 Added 383.38%	40,000 $1.92 Million
Q1 2020 May 12, 2020	BUY	$48.35 - $118.68 $11,749 - $28,839	243 Added 3.03%	8,275 $521,000
Q4 2019 Feb 05, 2020	SELL	$57.36 - $124.1 $18,871 - $40,828	-329 Reduced 3.93%	8,032 $995,000
Q3 2019 Nov 13, 2019	BUY	$58.69 - $80.46 $41,552 - $56,965	708 Added 9.25%	8,361 $555,000
Q2 2019 Aug 12, 2019	SELL	$77.77 - $120.68 $1 Million - $1.55 Million	-12,880 Reduced 62.73%	7,653 $609,000
Q1 2019 May 10, 2019	BUY	$91.83 - $120.68 $56,842 - $74,700	619 Added 3.11%	20,533 $2.3 Million
Q4 2018 Feb 14, 2019	BUY	$85.79 - $126.46 $1.02 Million - $1.5 Million	11,858 Added 147.19%	19,914 $2.01 Million
Q3 2018 Nov 14, 2018	BUY	$88.49 - $127.55 $96,808 - $139,539	1,094 Added 15.71%	8,056 $1.02 Million
Q2 2018 Aug 13, 2018	BUY	$60.0 - $85.67 $147,060 - $209,977	2,451 Added 54.33%	6,962 $0
Q1 2018 May 14, 2018	BUY	$52.72 - $67.25 $23,038 - $29,388	437 Added 10.73%	4,511 $278,000
Q4 2017 Feb 13, 2018	BUY	$58.2 - $72.76 $237,106 - $296,424	4,074	4,074 $238,000

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account